Herceptin 600 mg/5 mL Subcutaneous Solution
Herceptin 600 mg/5 mL Subcutaneous Solution was the first HER2-targeted therapy for breast cancer. It is a monoclonal antibody that binds to HER2 receptors present on the surface of HER2-positive tumour cells, blocking them from receiving growth signals and flagging them for destruction by the immune system.
Uses Herceptin 600 mg/5 mL
Herceptin is used to treat early-stage, locally advanced, and secondary breast cancer, as well as advanced gastric cancer. It can be used alone or in combination with chemotherapy.
Common side effects include infusion reactions like fever, chills, nausea, vomiting, pain, headache, dizziness, and shortness of breath. Serious side effects include heart problems like congestive heart failure or reduced heart function. Severe administration-related reactions, including hypersensitivity and anaphylaxis, have also been reported.
Trastuzumab may cause serious heart problems, including heart failure. The risk of heart problems is increased if you also use an anthracycline (such as doxorubicin). Your doctor may stop treatment with this medication if heart problems occur. Tell your doctor right away if you have any symptoms of heart failure (such as shortness of breath, swelling ankles/feet, unusual tiredness, unusual/sudden weight gain).
Serious (possibly fatal) breathing problems may happen with your injection, usually during or within 24 hours of the dose. Get medical help right away if you have coughing or trouble breathing.
Reviews
There are no reviews yet.